Registry of Lobbyists
Charles River Laboratories (CRL) provides products and services to help expedite the discovery, early-stage development, and safe manufacturing of novel drugs and therapeutics. CRL plays an essential role in delivering therapeutic breakthroughs that have positively transformed the quality of life for people in Canada and around the globe. It focuses on activities affecting the medical research community both nationally and internationally. Through its engagement, CRL is seeking to ensure that the Government of Canada understands the critical role it plays in ensuring the health and safety of Canadians and its business, economic, and scientific impact in Canada's healthcare ecosystem.
David Leroux-Petersen, Corporate Vice-President
End date of the last completed financial year: 2022-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Quebec Provincial Government (Sectorial committee -Pharmabio Developpement) | $50,425.20 | No |
Address:
251 Ballardvale Street
Wilmington, MA 01887
United States of America
Telephone number:
781-222-6000
Charles River Laboratories / Laboratoires Charles River is not a subsidiary of any other parent companies.
Charles River Laboratories / Laboratoires Charles River does not have any subsidiaries that could have a direct interest in the outcome of the undertaking